JP2023530997A5 - - Google Patents
Info
- Publication number
- JP2023530997A5 JP2023530997A5 JP2022578554A JP2022578554A JP2023530997A5 JP 2023530997 A5 JP2023530997 A5 JP 2023530997A5 JP 2022578554 A JP2022578554 A JP 2022578554A JP 2022578554 A JP2022578554 A JP 2022578554A JP 2023530997 A5 JP2023530997 A5 JP 2023530997A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- cdr
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063041421P | 2020-06-19 | 2020-06-19 | |
| US202063041450P | 2020-06-19 | 2020-06-19 | |
| US63/041,450 | 2020-06-19 | ||
| US63/041,421 | 2020-06-19 | ||
| US202163152811P | 2021-02-23 | 2021-02-23 | |
| US63/152,811 | 2021-02-23 | ||
| PCT/US2021/037920 WO2021257894A1 (en) | 2020-06-19 | 2021-06-17 | Anti-bst2 antibodies targeting bst2 long isoform |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023530997A JP2023530997A (ja) | 2023-07-20 |
| JP2023530997A5 true JP2023530997A5 (cg-RX-API-DMAC7.html) | 2024-06-24 |
| JP7902476B2 JP7902476B2 (ja) | 2026-08-10 |
Family
ID=79268440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022578554A Active JP7902476B2 (ja) | 2020-06-19 | 2021-06-17 | Bst2ロングアイソフォームを標的化する抗bst2抗体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12698335B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4168029A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7902476B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021257894A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121135899B (zh) * | 2025-11-19 | 2026-03-03 | 中国医学科学院病原生物学研究所 | 一种hiv抗性分子及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7408041B2 (en) | 2000-12-08 | 2008-08-05 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| JP4261882B2 (ja) | 2002-11-25 | 2009-04-30 | 泉陽興業株式会社 | 観覧車のゴンドラ |
| AU2005333155B2 (en) | 2005-03-14 | 2011-11-17 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibodies against Hendra and Nipah viruses |
| EP2064240A2 (en) * | 2006-09-18 | 2009-06-03 | Xencor, Inc. | Optimized antibodies that target hm1.24 |
| MX2010004251A (es) | 2007-10-16 | 2010-08-30 | Sbi Biotech Co Ltd | Anticuerpo anti-bst2. |
| WO2010065536A2 (en) | 2008-12-01 | 2010-06-10 | The Board Of Regents Of The University Of Texas System | Recombinant bone marrow stromal antigen-2 in the treatment of autoimmune diseases |
| NZ704771A (en) * | 2012-08-13 | 2018-02-23 | Regeneron Pharma | Anti-pcsk9 antibodies with ph-dependent binding characteristics |
| WO2015083791A1 (ja) | 2013-12-04 | 2015-06-11 | 国立研究開発法人理化学研究所 | 肺癌の検出方法および検出キット |
| US10676528B2 (en) | 2013-12-06 | 2020-06-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same |
| CN122399016A (zh) | 2014-03-15 | 2026-07-17 | 诺华股份有限公司 | 使用嵌合抗原受体治疗癌症 |
| WO2016016343A1 (en) | 2014-07-31 | 2016-02-04 | Cellectis | Ror1 specific multi-chain chimeric antigen receptor |
| EP3256135A4 (en) | 2015-02-09 | 2018-06-27 | Yeda Research and Development Co. Ltd. | Methods of preventing secondary infections |
| WO2016179319A1 (en) * | 2015-05-04 | 2016-11-10 | Cellerant Therapeutics, Inc. | Chimeric antigen receptors with ctla4 signal transduction domains |
| CN107619443B (zh) | 2016-07-14 | 2020-08-14 | 深圳宾德生物技术有限公司 | 抗人和鼠cd317的单克隆抗体及其制备方法和应用 |
| US10648987B2 (en) | 2017-06-15 | 2020-05-12 | Wayne State University | Methods and compositions relating to anti-HcTnT-N69 antibody for detection of cardiac disorders |
| CN109748964B (zh) | 2017-11-01 | 2020-11-17 | 深圳宾德生物技术有限公司 | CD317单链抗体317scFv、其编码序列及制备方法和应用 |
| WO2019165421A1 (en) | 2018-02-26 | 2019-08-29 | Minerva Biotechnologies Corporation | Diagnostic methods using anti-muc1* antibodies |
-
2021
- 2021-06-17 WO PCT/US2021/037920 patent/WO2021257894A1/en not_active Ceased
- 2021-06-17 JP JP2022578554A patent/JP7902476B2/ja active Active
- 2021-06-17 US US18/002,014 patent/US12698335B2/en active Active
- 2021-06-17 EP EP21825874.7A patent/EP4168029A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7844558B2 (ja) | リンパ球における阻害経路の中和 | |
| CN110291109B (zh) | 人程序性死亡受体pd-1的单克隆抗体及其片段 | |
| JP6767362B2 (ja) | リンパ球における阻害経路の中和 | |
| EP3986569A1 (en) | Dosing regimen and combination therapies for multispecific antibodies targeting b-cell maturation antigen | |
| EP4039705A1 (en) | Antibody targeting bcma, bispecific antibody, and use thereof | |
| CN109160949B (zh) | 一种鼠抗人pd-1单克隆抗体及应用 | |
| AU2015254886A1 (en) | Humanized antibodies against CEACAM1 | |
| KR20180008571A (ko) | 다발성 골수종(mm)의 치료 | |
| US20250179187A1 (en) | Anti pd-l2 antibody | |
| US20250179168A1 (en) | Materials and methods for treating stress-related disorders and cancer | |
| JP2025510642A5 (cg-RX-API-DMAC7.html) | ||
| JP2023521228A (ja) | 癌の併用療法 | |
| CN118339187A (zh) | 抗pd-1抗体及其用途 | |
| TW202005983A (zh) | 抗-人類pd-l1之抗體及其用途 | |
| EP4483899A1 (en) | Medicine comprising combination of anti-mutant-calr antibody and another drug | |
| US20230192833A1 (en) | New anti-VEGFC antibodies and uses thereof | |
| JP2024502670A5 (cg-RX-API-DMAC7.html) | ||
| CN116848144A (zh) | 抗pd-l1抗体及其用途 | |
| EP4428159A1 (en) | Melanoma targeting human antibodies and therapeutic uses thereof | |
| WO2024149224A1 (zh) | Ccr8抗体的应用 | |
| EP4712977A1 (en) | Uses of t cell engaging proteins in the treatment of cancer | |
| HK40121119A (en) | Medicine comprising combination of anti-mutant-calr antibody and another drug | |
| CN120092018A (zh) | 使用抗ctla4抗体治疗癌症的方法 | |
| RU2021128133A (ru) | Введение ингибиторов pd-1 для лечения рака кожи | |
| TH90421A (th) | แอนติบอดี้สำหรับ egfl7 และวิธีการสำหรับการใช้งานของสารเหล่านั้น |